This is the authors' abstract. We don't add key points for this paper.
A cell-active, mutant-specific, covalent inhibitor of KRAS(G12C) is described that targets the GDP-bound, inactive state and prevents subsequent activation. Using this novel compound, we demonstrate that KRAS(G12C) oncoprotein rapidly cycles bound nucleotide and responds to upstream signaling inputs to maintain a highly active state.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Patricelli et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: